Mark Manzano

1.3k total citations
21 papers, 1.0k citations indexed

About

Mark Manzano is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark Manzano has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark Manzano's work include Viral-associated cancers and disorders (10 papers), Mosquito-borne diseases and control (6 papers) and Circular RNAs in diseases (4 papers). Mark Manzano is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Mosquito-borne diseases and control (6 papers) and Circular RNAs in diseases (4 papers). Mark Manzano collaborates with scholars based in United States, Germany and Mexico. Mark Manzano's co-authors include Eva Gottwein, Radhakrishnan Padmanabhan, Filippos Klironomos, Nikolaus Rajewsky, Marcel Schilling, Andrei Filipchyk, Stefanie Grosswendt, Ajinkya Patil, Archana N. Raja and K. Nagarajan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Mark Manzano

19 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Manzano United States 15 561 266 223 219 172 21 1.0k
Wonkyung Oh United States 14 438 0.8× 77 0.3× 90 0.4× 179 0.8× 107 0.6× 20 682
Claudia M. Espitia United States 17 646 1.2× 111 0.4× 95 0.4× 270 1.2× 91 0.5× 39 1.1k
Krishna Kumar India 13 407 0.7× 105 0.4× 80 0.4× 289 1.3× 44 0.3× 28 946
Pamela Mukhopadhyay Australia 19 641 1.1× 123 0.5× 75 0.3× 196 0.9× 45 0.3× 32 970
Elodie Chapeaublanc France 12 378 0.7× 111 0.4× 61 0.3× 79 0.4× 100 0.6× 12 616
Monica Yabal Germany 14 1.0k 1.8× 174 0.7× 187 0.8× 144 0.7× 35 0.2× 18 1.4k
Yongxin Mu China 19 480 0.9× 162 0.6× 65 0.3× 102 0.5× 26 0.2× 33 905
Anirban Adhikari United States 8 914 1.6× 478 1.8× 102 0.5× 183 0.8× 38 0.2× 8 1.5k
Neta Milman United States 12 717 1.3× 409 1.5× 39 0.2× 99 0.5× 134 0.8× 19 928
Klaus Schwamborn France 14 751 1.3× 132 0.5× 113 0.5× 141 0.6× 22 0.1× 20 1.0k

Countries citing papers authored by Mark Manzano

Since Specialization
Citations

This map shows the geographic impact of Mark Manzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Manzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Manzano more than expected).

Fields of papers citing papers by Mark Manzano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Manzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Manzano. The network helps show where Mark Manzano may publish in the future.

Co-authorship network of co-authors of Mark Manzano

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Manzano. A scholar is included among the top collaborators of Mark Manzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Manzano. Mark Manzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tycko, Josh, et al.. (2025). Cytotoxicity of activator expression in CRISPR-based transcriptional activation systems. Nature Communications. 16(1). 8071–8071.
2.
Sifford, Jeffrey M., Gang� Li, Debopam Ghosh, et al.. (2025). Intrinsic p53 activation restricts gammaherpesvirus driven germinal center B cell expansion during latency establishment. Nature Communications. 16(1). 951–951. 1 indexed citations
3.
Forrest, J. Craig, et al.. (2024). Molecular Mechanisms of KSHV Latency Establishment and Maintenance. Current Clinical Microbiology Reports. 11(4). 220–230.
4.
Manzano, Mark, et al.. (2023). CRISPR screens identify novel regulators of cFLIP dependency and ligand-independent, TRAIL-R1-mediated cell death. Cell Death and Differentiation. 30(5). 1221–1234. 5 indexed citations
6.
Patil, Ajinkya, Mark Manzano, & Eva Gottwein. (2019). Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma. Blood Advances. 3(14). 2105–2117. 24 indexed citations
7.
Manzano, Mark, et al.. (2019). The Oncogenic Kaposi’s Sarcoma-Associated Herpesvirus Encodes a Mimic of the Tumor-Suppressive miR-15/16 miRNA Family. Cell Reports. 29(10). 2961–2969.e6. 16 indexed citations
8.
Manzano, Mark, Ajinkya Patil, Alexander Waldrop, et al.. (2018). Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma. Nature Communications. 9(1). 3263–3263. 49 indexed citations
9.
Patil, Ajinkya, Mark Manzano, & Eva Gottwein. (2018). CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma. Blood. 132(6). 577–586. 32 indexed citations
10.
Balasubramanian, Anuradha, Mark Manzano, T Teramoto, Rajendra Pilankatta, & Radhakrishnan Padmanabhan. (2016). High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. Antiviral Research. 134. 6–16. 30 indexed citations
11.
Manzano, Mark, Eleonora Forte, Archana N. Raja, Matthew J. Schipma, & Eva Gottwein. (2015). Divergent target recognition by coexpressed 5′-isomiRs of miR-142-3p and selective viral mimicry. RNA. 21(9). 1606–1620. 32 indexed citations
12.
Grosswendt, Stefanie, Andrei Filipchyk, Mark Manzano, et al.. (2014). Unambiguous Identification of miRNA:Target Site Interactions by Different Types of Ligation Reactions. Molecular Cell. 54(6). 1042–1054. 224 indexed citations
13.
Boonyasuppayakorn, Siwaporn, et al.. (2014). Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity. Antiviral Research. 106. 125–134. 90 indexed citations
14.
Manzano, Mark, Janak Padia, & Radhakrishnan Padmanabhan. (2014). Small Molecule Inhibitor Discovery for Dengue Virus Protease Using High-Throughput Screening. Methods in molecular biology. 1138. 331–344. 5 indexed citations
15.
Zhang, Weiying, Yuhao Shi, Mark Manzano, et al.. (2014). Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma. Science Signaling. 7(324). ra42–ra42. 293 indexed citations
16.
Forte, Eleonora, Archana N. Raja, Mark Manzano, et al.. (2014). MicroRNA-Mediated Transformation by the Kaposi's Sarcoma-Associated Herpesvirus Kaposin Locus. Journal of Virology. 89(4). 2333–2341. 31 indexed citations
17.
Teramoto, T, Hao-Sen Chiang, Ratree Takhampunya, et al.. (2013). Gamma interferon-inducible lysosomal thioreductase (GILT) ablation renders mouse fibroblasts sensitive to dengue virus replication. Virology. 441(2). 146–151. 15 indexed citations
18.
Manzano, Mark, et al.. (2013). Kaposi's Sarcoma-Associated Herpesvirus Encodes a Mimic of Cellular miR-23. Journal of Virology. 87(21). 11821–11830. 33 indexed citations
19.
Manzano, Mark, et al.. (2011). Identification of Cis-Acting Elements in the 3′-Untranslated Region of the Dengue Virus Type 2 RNA That Modulate Translation and Replication. Journal of Biological Chemistry. 286(25). 22521–22534. 83 indexed citations
20.
Alcaráz‐Estrada, Sofía Lizeth, Mark Manzano, Rosa María del Ángel, Robin Levis, & Radhakrishnan Padmanabhan. (2010). Construction of a dengue virus type 4 reporter replicon and analysis of temperature-sensitive mutations in non-structural proteins 3 and 5. Journal of General Virology. 91(11). 2713–2718. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026